La Jolla, CA, United States of America

Stephanie M Stanford

USPTO Granted Patents = 5 


Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovative Contributions of Stephanie M Stanford in Fibrotic Disease Research

Introduction

Stephanie M Stanford is a noteworthy inventor based in La Jolla, California, known for her significant contributions to the field of biomedical research, particularly in the study and treatment of fibrotic diseases. With a total of five patents to her name, Stanford is impacting the landscape of medical therapies through her innovative approaches.

Latest Patents

Her most recent patents include a novel method targeting PTP4A1 as a therapeutic solution for fibrotic diseases and disorders, including systemic sclerosis (SSc). This groundbreaking research provides methods for administering an effective amount of an antagonist or inhibitor that can modulate PTP4A1 protein expression or activity, thereby offering potential treatments for organ or skin fibrosis associated with SSc. Another significant patent involves inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP), showcasing methods for utilizing compounds that can effectively modulate the activity levels of this protein. The structure of these compounds is detailed in the provided formula.

Career Highlights

Stanford's career features notable affiliation with leading research institutions, such as the La Jolla Institute for Allergy and Immunology and the Sanford Burnham Prebys Medical Discovery Institute. These roles have allowed her to broaden her research scope and contribute to advancements in biomedical science.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues, including Nunzio Bottini and Jiwen Zou. These partnerships have fostered an environment for innovation, leading to significant advancements in her research areas.

Conclusion

In conclusion, Stephanie M Stanford exemplifies the role of an innovative inventor in the realm of medical research. Her dedication to exploring therapeutic targets for fibrotic diseases through her patents paves the way for new treatment possibilities, highlighting her contribution to improving patient outcomes in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…